TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin-Reference-Cited by-同舟云学术

TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin

Published:2015-09 Issue:3 Volume:138 Page:627-633
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Erriquez J.,Becco P.,Olivero M.,Ponzone R.,Maggiorotto F.,Ferrero A.,Scalzo M.S.,Canuto E.M.,Sapino A.,Verdun di Cantogno L.,Bruna P.,Aglietta M.,Di Renzo M.F.,Valabrega G.

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference37 articles.

1. Optimal first-line treatment in ovarian cancer;Raja;Ann. Oncol.,2012

2. Overcoming platinum resistance in ovarian carcinoma;Matsuo;Expert Opin. Investig. Drugs,2010

3. Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer;Lawrie;Cochrane Database Syst. Rev.,2013

4. Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer;Monk;J. Clin. Oncol.,2010

5. Topoisomerase II: a fitted mechanism for the chromatin landscape;Roca;Nucleic Acids Res.,2009

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening and identification of key genes between high-grade and low-grade serous ovarian carcinomas using integrated bioinformatics;2024-08-05

2. Insights into the structure–function relationship of missense mutations in the human TOP2A protein in ovarian cancer;Frontiers in Physics;2024-03-28

3. TOP2A modulates signaling via the AKT/mTOR pathway to promote ovarian cancer cell proliferation;Cancer Biology & Therapy;2024-03-06

4. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma;Scientific Reports;2023-05-29

5. Cryptolepine Targets TOP2A and Inhibits Tumor Cell Proliferation in Breast Cancer Cells - An In vitro and In silico Study;Anti-Cancer Agents in Medicinal Chemistry;2022-10